Concepedia

Celeste M. DiGloria

CM

5

Publications

233

Citations

5

H-Index

2014

Active since

Affiliations

Harvard University(Current)

Massachusetts General Hospital

Celeste M. DiGloria is an author at Harvard University specializing in tumor biology, health sciences, and cancer therapeutics.

Top concepts

Publications per year

2014–2019

5

Publications

5

Inhibition of Notch Signaling in Combination with Paclitaxel Reduces Platinum-Resistant Ovarian Tumor Growth

Jolijn W. Groeneweg, Celeste M. DiGloria, Jing Yuan et al. · Frontiers in Oncology · 2014 · 58 citations · Full text

PARP Inhibition Induces Enrichment of DNA Repair–Proficient CD133 and CD117 Positive Ovarian Cancer Stem Cells

Chiara Bellio, Celeste M. DiGloria, Rosemary Foster et al. · Molecular Cancer Research · 2018 · 57 citations

Dual HER2 Targeting Impedes Growth of <i>HER2</i> Gene–Amplified Uterine Serous Carcinoma Xenografts

Jolijn W. Groeneweg, Sílvia Hernández, Virginia F. Byron et al. · Clinical Cancer Research · 2014 · 41 citations · Full text

The Metabolic Inhibitor CPI-613 Negates Treatment Enrichment of Ovarian Cancer Stem Cells

Chiara Bellio, Celeste M. DiGloria, David R. Spriggs et al. · Cancers · 2019 · 40 citations · Full text

, , +15

HER2 over-expressing high grade endometrial cancer expresses high levels of p95HER2 variant

Whitfield B. Growdon, Jolijn W. Groeneweg, Virginia F. Byron et al. · Gynecologic Oncology · 2015 · 37 citations · Full text

Rows per page

1–5 of 5